Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Cited by (1,003)

Items 401–500 of 1,003

1. COVID‐19 and immunological regulations – from basic and translational aspects to clinical implications
   Michael Peter Schön, Carola Berking, Tilo Biedermann, Timo Buhl, Luise Erpenbeck, Kilian Eyerich, Stefanie Eyerich, Kamran Ghoreschi, Matthias Goebeler, Ralf Joachim Ludwig et al. · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
2. SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
   Wei Chen, Jie Zhang, Xijian Qin, Weixiao Wang, Miaomiao Xu, Lin‐Fa Wang, Chuanjun Xu, Shuangshuang Tang, Pei Liu, Libo Zhang et al. · 2020 · Biomedicine & Pharmacotherapy
3. Autoimmunity as the comet tail of COVID-19 pandemic
   Rossella Talotta, Erle S. Robertson · 2020 · World Journal of Clinical Cases
4. SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response
   Mar Masiá, Guillermo Telenti, Marta Fernández‐González, José Alberto García, Vanesa Agulló, Sergio Padilla, Javier García‐Abellán, Lucía Guillén, Paula Mascarell, José C Asenjo et al. · 2021 · Open Forum Infectious Diseases
5. Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
   Ross Harris, Heather Whitaker, Nick J Andrews, Felicity Aiano, Zahin Amin‐Chowdhury, Jessica S. Flood, Ray Borrow, Ezra Linley, Shazaad S. Y. Ahmad, Lorraine Stapley et al. · 2021 · Journal of Infection
6. Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS‐CoV‐2)
   Yong Gao, Yi Yuan, Tuantuan Li, Wang Xiaowu, Xiuyong Li, Ang Li, Han Mingfeng · 2020 · Journal of Medical Virology
7. Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests
   Marianna Theresia Traugott, Stephan Walter Aberle, Judith Helene Aberle, Hannah Griebler, Mario Karolyi, Erich Pawelka, Elisabeth Puchhammer‐Stöckl, Alexander Zoufaly, Lukas Weseslindtner · 2020 · The Journal of Infectious Diseases
8. Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2
   Raymond T. Suhandynata, Melissa A. Hoffman, Deli Huang, Jenny Tuyet Tran, Michael J. Kelner, Sharon L. Reed, Ronald W. McLawhon, James E. Voss, David A. Nemazee, Robert L. Fitzgerald · 2020 · Clinical Chemistry
9. Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry
   John V. Dzimianski, Nicholas Lorig‐Roach, Sara M. O’Rourke, David L. Alexander, Jacqueline M. Kimmey, Rebecca M. DuBois · 2020 · Scientific Reports
10. Primary Care’s Historic Role in Vaccination and Potential Role in COVID-19 Immunization Programs
    Elizabeth C. Wilkinson, Anuradha Jetty, Stephen M. Petterson, Yalda Jabbarpour, John M. Westfall · 2021 · The Annals of Family Medicine
11. The Prevalence of Antibodies to SARS-CoV-2 Among Blood Donors in China
    Le Chang, Wangheng Hou, Lei Zhao, Yali Zhang, Yanbin Wang, Linfeng Wu, Tingting Xu, Lilin Wang, Juan Wang, Jian Ma et al. · 2020 · Nature Communications
12. Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical Validation
    Olalla Calvo-Lozano, Miquel Sierra, Maria Soler, M.‐Carmen Estévez, Luis Chiscano‐Camón, Adolfo Ruiz-Sanmartín, Juan Carlos Ruiz‐Rodríguez, Ricard Ferrer, Juan José González‐López, Juliana Esperalba et al. · 2021 · Analytical Chemistry
13. Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications
    Saverio Caini, Federica Bellerba, Federica Corso, Angélica Díaz‐Basabe, Gioacchino Natoli, John Paget, Federica Facciotti, Simone Pietro De Angelis, Sara Raimondi, Domenico Palli et al. · 2020 · Eurosurveillance
14. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients
    Kirsten Alexandra Eberhardt, Charlotte Meyer‐Schwickerath, Eva Heger, Elena Knops, Clara Lehmann, Jan Rybniker, Philipp Schommers, Dennis Alexander Eichenauer, Florian Kurth, Michael Ramharter et al. · 2020 · Viruses
15. Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)
    Silvia Vivarelli, Luca Falzone, Francesco Torino, Giuseppa Scandurra, Giulia Lo Russo, Roberto Bordonaro, Francesco Pappalardo, Demetrios A. Spandidos, Giuseppina Raciti, Massimo Libra · 2020 · International Journal of Oncology
16. A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies
    Zhong Yao, Luka Drecun, Farzaneh Aboualizadeh, Sun Jin Kim, Zhijie Li, Heidi Wood, Emelissa J. Valcourt, Kathy Manguiat, Simon W. Plenderleith, Lily Yip et al. · 2021 · Nature Communications
17. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
    Tamás Pongrácz, Jan Nouta, Wenjun Wang, Krista E. van Meijgaarden, Federica Caterina Linty, Gestur Vidarsson, Simone A. Joosten, Tom H. M. Ottenhoff, Cornelis Hendrik Hokke, Jutte J.C. de Vries et al. · 2022 · EBioMedicine
18. Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19
    Nil Albiol, Rahinatu Awol, Rodrigo Martino · 2020 · Annals of Hematology
19. Types of Assays for SARS-CoV-2 Testing: A Review
    Marie C. Smithgall, Mitra Dowlatshahi, Steven L. Spitalnik, Eldad A. Hod, Alex J Rai · 2020 · Laboratory Medicine
20. Screening for SARS‐CoV ‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
    Silvano Wendel, José Mauro Kutner, Rafael Rahal Guaragna Machado, Rita Fontão‐Wendel, Carolina Bonet Bub, Roberta Maria Fachini, Ana Paula Hitomi Yokoyama, Gabriela de Toledo Passos Candelaria, Araci Massami Sakashita, Ruth Achkar et al. · 2020 · Transfusion
21. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan
    Yuki Nakano, Makoto Kurano, Yoshifumi Morita, Takuya Shimura, Rin Yokoyama, Chungen Qian, Fuzhen Xia, Fan He, Yoshiro Kishi, Jun Okada et al. · 2021 · Scientific Reports
22. Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
    Charlotte Manisty, Thomas Alexander Treibel, Melanie P. Jensen, Amanda E. Semper, George Joy, Rishi K Gupta, Teresa Cutiño‐Moguel, Mervyn Andiapen, Jessica Jones, Stephen Charles Taylor et al. · 2021 · EBioMedicine
23. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre‐pandemic controls
    Kiwook Jung, Sue Shin, Minjeong Nam, Yun Ji Hong, Eun Youn Roh, Kyoung Un Park, Eun Young Song · 2021 · Journal of Clinical Laboratory Analysis
24. Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreak
    Susanne Brandstetter, Samra Roth, Susanne Harner, Heike Buntrock‐Döpke, Antoaneta A. Toncheva, Natascha S. Borchers, Rudolf Gruber, Andreas Ambrosch, Michael Kabesch · 2020 · Pediatric Allergy and Immunology
25. Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States
    Monica Fung, Charles Y. Chiu, Catherine DeVoe, Sarah B. Doernberg, Brian S. Schwartz, Charles Langelier, Timothy J. Henrich, Deborah S. Yokoe, John A. Davis, Steven R. Hays et al. · 2020 · American Journal of Transplantation
26. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID‐19 convalescent plasma clinical trial
    Maria Lucia L. Madariaga, Jenna J. Guthmiller, Stephen J. Schrantz, Maud O. Jansen, Chancey Christensen, Madan Kumar, Megan Prochaska, Geoffrey D. Wool, Amy Durkin Celauro, Won Hee Oh et al. · 2020 · Journal of Internal Medicine
27. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines
    Mohd. Iqbal Yatoo, Zeenat Hamid, Oveas Rafiq Parray, Aasim Habib Wani, Abrar Ul Haq, Archana Saxena, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Yashpal Singh Malik et al. · 2020 · Human Vaccines & Immunotherapeutics
28. Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals
    Hongyu Wang, Jingwen Ai, Michael J. Loeffelholz, Yi‐Wei Tang, Wenhong Zhang · 2020 · Emerging Microbes & Infections
29. IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2
    Mary Kathryn Bohn, Tze Ping Loh, Cheng-Bin Wang, Robert Mueller, David D. Koch, Sunil Kumar Sethi, William D. Rawlinson, Massimo Clementi, Rajiv Timothy Erasmus, Marc Leportier et al. · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
30. Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study
    Anuja Pandit, Nirav Chandulal Bhalani, B.L. Shashi Bhushan, Parshottam Koradia, Shweta Gargiya, Vinay Bhomia, Kevinkumar Kansagra · 2021 · International Journal of Infectious Diseases
31. Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting
    Lisa Müller, Philipp Niklas Ostermann, Andreas Walker, Tobias Wienemann, Alexander Mertens, Ortwin Adams, Marcel Andrée, Sandra Hauka, Nadine Lübke, Verena Keitel et al. · 2021 · European Journal of Clinical Microbiology & Infectious Diseases
32. Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing
    Zehui Zhang, Xiaoqin Wang, Xiaojun Wei, Sophia W. Zheng, Brian J. Lenhart, Peisheng Xu, Jie Li, Jing Pan, Helmut Albrecht, Chang Liu · 2021 · Biosensors and Bioelectronics
33. Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study
    Nathanaël Hozé, Juliette Paireau, Nathanaël Lapidus, Cécile Tran Kiem, Henrik Salje, Gianluca Severi, Mathilde Touvier, Marie Zins, Xavier Nicolas de Lamballerie, Daniel Lévy-Bruhl et al. · 2021 · The Lancet Public Health
34. COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies
    Francesco Passamonti, Alessandra Romano, Marco Salvini, Francesco Merli, Matteo Giovanni Della Porta, Riccardo Bruna, Elisa Coviello, Ilaria Jane Romano, Roberto Cairoli, Roberto Massimo Lemoli et al. · 2021 · British Journal of Haematology
35. Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects
    Jiaxin Zheng, Yingying Deng, Zhenyu Zhao, Binli Mao, Meng-Ji Lu, Yong Lin, Ai-long Huang · 2021 · Cellular & Molecular Immunology
36. Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies
    Lian C. T. Shoute, Gaser Nagah Abdelrasoul, Yuhao Ma, Pedro Augusto Silva Duarte, Cole Edwards, Ran Zhuo, Jie Zeng, Yiwei Feng, Carmen L. Charlton, Jamil N. Kanji et al. · 2023 · Microsystems & Nanoengineering
37. The diagnostic methods in the COVID-19 pandemic, today and in the future
    So Yat Wu, Hoi Shan Yau, Man Yu, Hin Fung Tsang, Lawrence Chan, William Chi Shing Cho, Allen Chi-Shing Yu, Aldrin Kay‐Yuen Yim, Marco J W Li, Yin Kwan Evelyn Wong et al. · 2020 · Expert Review of Molecular Diagnostics
38. Development of a Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of SARS-CoV-2 Spike Glycoprotein and Nucleoprotein
    Lisa H. Cazares, Raghothama Chaerkady, Shao Huan Samuel Weng, Chelsea C. Boo, Raffaello Cimbro, Hsiang-En Hsu, Sarav Rajan, William F. Dall’Acqua, Lori Clarke, Kuishu Ren et al. · 2020 · Analytical Chemistry
39. Characterization of antibody responses to SARS‐CoV‐2 in convalescent COVID‐19 patients
    Chuanmiao Liu, Xiaoqi Yu, Chunming Gao, Li Zhang, Hui Zhai, Yanan Hu, Enhui Liu, Qiong Wang, Yu Gao, Dong Wei et al. · 2020 · Journal of Medical Virology
40. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020
    Robert Flisiak, Miłosz Parczewski, Andrzej Horban, Jerzy Jaroszewicz, Dorota Kozielewicz, Małgorzata Pawłowska, Anna Piekarska, Krzysztof Adam Simon, Krzysztof Tomasiewicz, Dorota Zarębska‐Michaluk · 2020 · Polskie Archiwum Medycyny Wewnętrznej
41. COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
    Muhammad Umer Ashraf, Yeji Kim, Sunil Kumar, Dongyeob Seo, Maryam Ashraf, Yong‐Soo Bae · 2021 · Vaccines
42. SARS-CoV-2 Antibody Seroprevalence and Associated Risk Factors in an Urban District in Cameroon
    Kenechukwu Obumneme Samuel Nwosu, Joseph Fokam, Franck Wanda, Lucien Mama, Erol Orel, Nicolas Ray, Jeanine Meke, Armel Tassegning, Désiré Takou, Eric Mimbe et al. · 2021 · Nature Communications
43. COVID-19 Immunity Passport to Ease Travel Restrictions?
    Lin H. Chen, D. Freedman, L. Visser · 2020 · Journal of Travel Medicine
44. SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics
    Daniela Basso, Ada Aita, Filippo Navaglia, Elisa Franchin, Paola Fioretto, Stefania Moz, Dania Bozzato, Carlo‐Federico Zambon, Barbara Martin, Chiara Dal Prà et al. · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
45. Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding
    Puja Adhikari, Neng Li, Matthew D. Shin, Nicole F. Steinmetz, Reidun Twarock, Rudolf Podgornik, W. Y. Ching · 2020 · Physical Chemistry Chemical Physics
46. Pharmaceutical nanotechnology: which products are been designed against COVID-19?
    Iago Dillion Lima Cavalcanti, Mariane Cajubá de Britto Lira Nogueira · 2020 · Journal of Nanoparticle Research
47. Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages
    Briza Pérez‐López, Mònica Mir · 2020 · Talanta
48. Immune reactivity during COVID-19: Implications for treatment
    Claudio Napoli A, Giuditta Benincasa, Clelia Criscuolo, Mario Faenza, Cinzia Liberato, Mariangela Rusciano · 2021 · Immunology Letters
49. Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study
    Kanika Kuwelker, Fan Zhou, Bjørn Blomberg, Sarah Larteley Lartey, Karl Albert Brokstad, Mai-Chi Trieu, Amit Bansal, Anders Madsen, Florian Krammer, Kristin Greve-Isdahl Mohn et al. · 2021 · The Lancet Regional Health - Europe
50. Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
    Elizabeth Fraley, Cas LeMaster, Eric S. Geanes, Dithi Banerjee, Santosh Khanal, Elin Grundberg, Rangaraj Selvarangan, Todd Bradley · 2021 · BMC Medicine
51. Sensitive sandwich-type electrochemical SARS-CoV‑2 nucleocapsid protein immunosensor
    Ceren Karaman, Bahar Bankoğlu Yola, Onur Karaman, Necip Atar, İlknur Polat, Mehmet Lütfi Yola · 2021 · Microchimica Acta
52. Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis
    Yinjun Mao, Weiwei Wang, Jun Ma, Shanshan Wu, Feng Sun · 2021 · Chinese Medical Journal
53. Risk of mortality in COVID-19 patients: a meta- and network analysis
    Rasoul Kowsar, Amir Mohammad Rahimi, Magdalena Sroka, Alireza Mansouri, Khaled Sadeghi, Elham Bonakdar, Sayed Farshad Kateb, Amir Hossein Mahdavi · 2023 · Scientific Reports
54. Applications and prospects of cryo-EM in drug discovery
    Kongfu Zhu, Chuang Yuan, Yongming Du, Kailei Sun, Xiaokang Zhang, Horst Vogel, Xudong Jia, Yuanzhu Gao, Qinfen Zhang, Daping Wang et al. · 2023 · Military Medical Research
55. COVID-19 reinfection: prolonged shedding or true reinfection?
    Shahab Falahi, Azra Kenarkoohi · 2020 · New Microbes and New Infections
56. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
    Amal Hasan, Ebaa Al‐Ozairi, Zahraa Albaqsumi, Rasheed Ahmad, Fahd Al‐Mulla · 2021 · ImmunoTargets and Therapy
57. Deep Learning for SARS COV-2 Genome Sequences
    Albert Whata, Charles Chimedza · 2021 · IEEE Access
58. Understanding COVID-19 in children: immune determinants and post-infection conditions
    Gioacchino Andrea Rotulo, Paolo Palma · 2023 · Pediatric Research
59. The close relationship between sudden loss of smell and COVID-19
    Lúcia Joffily, Aluan Ungierowicz, Andrea Goldwasser David, Bruna Melo, César Leandro Terra Brito, Luciane F. Mello, Priscilla de Souza Campos dos Santos, Rogério Pezato · 2020 · Brazilian Journal of Otorhinolaryngology
60. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)
    Feng‐Yee Chang, Hsiang‐Cheng Chen, Pei‐Jer Chen, Mei-Shang Ho, Shie-Liang Edmond Hsieh, Jung‐Chung Lin, Fu‐Tong Liu, Huey‐Kang Sytwu · 2020 · Journal of Biomedical Science
61. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
    Fleur Wolff, Hafid Dahma, Cécile Duterme, Sigi Van den Wijngaert, Olivier Vandenberg, FREDERIC JAY COTTON, Isabel Montesinos · 2020 · Diagnostic Microbiology and Infectious Disease
62. Immune responses in mildly versus critically ill COVID-19 patients
    Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, Mahsa Eshkevar Vakili, Paria Heydarinezhad, Narges Karami, Maryam Noroozi, Seppo Meri, Kurosh Kalantar · 2023 · Frontiers in Immunology
63. Antibody Profiles in Mild and Severe Cases of COVID-19
    Zhili Liu, Yang Liu, La‐Gen Wan, Tian-Xin Xiang, Aiping Le, Peng Liu, Malik J. S. Peiris, Leo L. M. Poon, Wei Zhang · 2020 · Clinical Chemistry
64. Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review
    Francesco Sessa, Giuseppe Bertozzi, Luigi Cipolloni, Benedetta Baldari, Santina Cantatore, Stefano D’Errico, Giulio Di Mizio, Alessio Asmundo, Sergio Castorina, Monica Salerno et al. · 2020 · Journal of Clinical Medicine
65. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action
    Somayeh Sadeghi, Sara Soudi, Abbas Shafiee, Seyed Mahmoud Hashemi · 2020 · Life Sciences
66. Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish Experience
    Beatriz Domínguez‐Gil, Mario Fernández‐Ruiz, Domingo Hernández, Marta Crespo, Jordi Colmenero, Elisabeth Coll, Juan José Rubio · 2020 · Transplantation
67. Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
    Anwar M. Hashem, Abdullah A. Algaissi, Sarah A. Almahboub, Mohamed A. Alfaleh, Turki S. Abujamel, Sawsan S. Alamri, Khalid A. Alluhaybi, Haya I. Hobani, Rahaf H. Alharbi, Reem M. Alsulaiman et al. · 2020 · Viruses
68. Clinical laboratory evaluation of COVID-19
    Zhufeng Chen, Wanju Xu, Wanshan Ma, Xiaohong Shi, Shuomin Li, Mingju Hao, Yuanxun Fang, Li Zhang · 2021 · Clinica Chimica Acta
69. CRISPR-based systems for sensitive and rapid on-site COVID-19 diagnostics
    Jun Hui Soh, Enrique Balleza, Muhammad Nadjad Abdul Rahim, Hsi‐Min Chan, Siswand Mohd Ali, Jacqueline Kai Chin Chuah, Sherif Edris, Ahmed Atef, Ahmed Bahieldin, Jackie Y. Ying et al. · 2022 · Trends in biotechnology
70. Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
    Susan E. Prockop, Aisha Nasreen Hasan, Ekaterina S. Doubrovina, Parastoo Bahrami Dahi, Irene Rodriguez-Sanchez, Michael Curry, Audrey Mauguen, Genovefa A. Papanicolaou, Yiqi Su, JinJuan Yao et al. · 2023 · Journal of Clinical Investigation
71. The variability of the serological response to SARS‐corona virus‐2: Potential resolution of ambiguity through determination of avidity (functional affinity)
    Georg Bauer · 2020 · Journal of Medical Virology
72. Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing
    Steven E. Conklin, Kathryn Martin, Yukari Carol Manabe, Haley A. Schmidt, Jernelle Miller, Morgan Keruly, Ethan Klock, Charles S. Kirby, Owen R. Baker, Reinaldo E. Fernández et al. · 2020 · Journal of Clinical Microbiology
73. Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2
    Krystle K. Q. Yu, Stephanie Fischinger, Malisa T. Smith, Caroline G. Atyeo, Deniz Cizmeci, Caitlin R. Wolf, Erik D. Layton, Jennifer K. Logue, Melissa S. Aguilar, Kiel D. Shuey et al. · 2021 · JCI Insight
74. Consequences of COVID-19 for the Pancreas
    Urszula Abramczyk, Maciej Nowaczyński, Adam Słomczyński, Piotr Wojnicz, Piotr Zatyka, Aleksandra Kuzan · 2022 · International Journal of Molecular Sciences
75. Testing for SARS-CoV-2: Can We Stop at 2?
    Tau Hong Lee, Susan Kline, Raymond Tzer Pin Lin, Timothy Barkham, Pooja Rao, Yee‐Sin Leo, David Chien Lye, Barnaby Edward Young · 2020 · Clinical Infectious Diseases
76. SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19
    Vivian Glück, Sonja Grobecker, Leonid Tydykov, Bernd Salzberger, Thomas Glück, Tanja Weidlich, Manuela Bertok, Christine Gottwald, Jürgen J. Wenzel, André Gessner et al. · 2021 · Infection
77. The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
    Mohamed Moubarak, Keneth Iceland Kasozi, ‏Helal F. Hetta, Hazem Mohammed Shaheen, Abdur Rauf, Hayder Mutter Al-Kuraishy, Safaa Y. Qusti, Eida Mohammed Alshammari, Emmanuel Tiyo Ayikobua, Fred Ssempijja et al. · 2021 · Life
78. Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China
    Yang Yang, Liping Guo, Jing Yuan, Zhixiang Xu, Yuchen Gu, Jiaqi Zhang, Yuan Guan, Jinhu Liang, Hongzhou Lu, Yingxia Liu · 2023 · The Lancet Microbe
79. Evaluation of recombinant nucleocapsid and spike proteins for serological diagnosis of novel coronavirus disease 2019 (COVID-19)
    Pingping Zhang, Qi Gao, Tang Wang, Yuehua Ke, Fei Mo, Ruizhong Jia, Wanbing Liu, Lei Liu, Shangen Zheng, Yuzhen Liu et al. · 2020 · medRxiv
80. Cellular immune responses to covid-19
    Herb F. Sewell, Raymond M Agius, Marcia Stewart, Denise Kendrick · 2020 · BMJ
81. Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis
    Fan Wu, Renhong Yan, Mei Liu, Zezhong Liu, Yingdan Wang, Die Luan, Kaiyue Wu, Zhigang Song, Tingting Sun, Yunping Ma et al. · 2020 · medRxiv
82. Herd immunity is not a realistic exit strategy during a COVID-19 outbreak
    Ed Slot, Boris M. Hogema, Chantal B. E. M. Reusken, Johan H J Reimerink, Michel Molier, Jan H. M. Karregat, Johan IJlst, Vĕra M J Novotny, René A. W. van Lier, Hans L. Zaaijer · 2020 · Research Square
83. Coronavirus Disease 2019: Clinical Review
    Cristina Carvalho Gouveia, Luís Campos · 2020 · Acta Médica Portuguesa
84. Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID‐19 patients
    Reza Soleimani, Mehdi Khourssaji, Damien Gruson, Hector Rodriguez‐Villalobos, Mathilde Berghmans, Leïla Belkhir, Jean Cyr Yombi, Benoît Kabamba‐Mukadi · 2020 · Journal of Medical Virology
85. Diagnostic Accuracy Estimates for COVID-19 Real-Time Polymerase Chain Reaction and Lateral Flow Immunoassay Tests With Bayesian Latent-Class Models
    Polychronis Kostoulas, Paolo Eusebi, Sonja Hartnack · 2021 · American Journal of Epidemiology
86. Correlates of Vaccine-Induced Protection against SARS-CoV-2
    Till Koch, Sibylle C. Mellinghoff, Parichehr Shamsrizi, Marylyn M. Addo, Christine Dahlke · 2021 · Vaccines
87. Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial
    Simon Jochum, Imke Kirste, Sayuri Hortsch, Veit Peter Grunert, Holly M. Legault, Udo Eichenlaub, Basel Kashlan, Rolando Pajón · 2022 · Frontiers in Immunology
88. SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studies
    Amy E. Benefield, Laura Skrip, Andrea Clement, Rachel A. Althouse, Stewart T. Chang, Benjamin M. Althouse · 2020 · medRxiv
89. Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study
    Dami A. Collier, Sonny Michael Assennato, Ben Warne, Nyaradzai Sithole, Katherine Sharrocks, Allyson V. Ritchie, Pooja Ravji, Matthew Routledge, Dominic Sparkes, Jordan P. Skittrall et al. · 2020 · Cell Reports Medicine
90. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
    Jon Hazeldine, Janet M. Lord · 2020 · Frontiers in Immunology
91. Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection
    Yu Zhang, Chui Mei Ong, Cassandra A. Yun, Weike Mo, Jeffrey D. Whitman, Kara L. Lynch, Alan H.B. Wu · 2021 · Clinical Chemistry
92. Vaccination versus infection with SARS‐CoV‐2: Establishment of a high avidity IgG response versus incomplete avidity maturation
    Friedhelm Struck, Patrick A. Schreiner, Eva Staschik, Karin Wochinz‐Richter, Sarah Schulz, Erwin Soutschek, Manfred Motz, Georg Bauer · 2021 · Journal of Medical Virology
93. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis
    Tawanda Chivese, Joshua T. Matizanadzo, Omran A. H. Musa, George Hindy, Luis Furuya‐Kanamori, Nazmul Islam, Rafal Al-Shebly, Rana Shalaby, Mohammad Habibullah, Talal A. Al-Marwani et al. · 2022 · Pathogens and Global Health
94. Why COVID-19 models should incorporate the network of social interactions
    Helena A. Herrmann, Jean‐Marc Schwartz · 2020 · Physical Biology
95. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection
    Catharina Gerhards, Margot Thiaucourt, Maximilian Kittel, Celine Becker, Volker Ast, Michael Hetjens, Michael Neumaier, Verena Haselmann · 2021 · International Journal of Infectious Diseases
96. Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19
    Madalina Elena Carter-Timofte, Sofie E. Jørgensen, Mette Ratzer Freytag, Michelle M. Thomsen, Nanna-Sophie Brinck Andersen, Ali Al-Mousawi, Alon Schneider Hait, Trine Hyrup Mogensen · 2020 · Frontiers in Immunology
97. Insight into the pediatric and adult dichotomy of COVID‐19: Age‐related differences in the immune response to SARS‐CoV‐2 infection
    Allison Fialkowski, Yaël Gernez, Puneeta Arya, Katja Gabriele Weinacht, Thomas Bernard Kinane, Lael M. Yonker · 2020 · Pediatric Pulmonology
98. The Antibody Response to SARS-CoV-2 Infection
    Linda Hueston, Jen Kok, Ayla Guibone, Damien McDonald, George Hone, James Goodwin, Ian W.J. Carter, Kerri Basile, Indy Sandaradura, Susan Maddocks et al. · 2020 · Open Forum Infectious Diseases
99. Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2
    Antonio Marra, Daniele Generali, Paola Zagami, Valeria Cervoni, Sara Gandini, Sergio Venturini, Stefania Morganti, Rita Passerini, Roberto Orecchia, Giuseppe Curigliano · 2020 · Annals of Oncology
100. Evaluating ELISA, Immunofluorescence, and Lateral Flow Assay for SARS-CoV-2 Serologic Assays
     Moïse Michel, Amar Bouam, Sophie Edouard, Florence Fenollar, Fabrizio Di Pinto, Jean‐Louis Mège, Michel Drancourt, Joana Vitte · 2020 · Frontiers in Microbiology